Definitive Contract 75F40121C00051
Award Date
6/15/21
Potential Completion Date
8/2/22
Potential Value
$86K
Federal Agency
Food and Drug Administration
Awardee
Novabioassays LLC
Ultimate Awardee
Not listed
NAICS Category
561320 - Temporary Help Services
PSC Category
Q999 - Medical- Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>This is a firm-fixed labor hour contract for $202,200.00 awarded by the Food and Drug Administration (FDA), a civilian government agency, to Novabioassays LLC, a for-profit limited liability company. The contract is for protein characterization services to be performed in Silver Spring, MD. The contract has an ultimate completion date of August 13, 2025 and was awarded on August 7, 2023. This is a firm fixed price contract and does not have a set-aside designation.</p>
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $236,975.76 firm-fixed-price purchase order to Nova Biomedical Corp, a manufacturer of in-vitro diagnostic equipment, to procure Nova Bioprofile Flex 2 operational parts and components. This contract has a completion date of January 31, 2024 and was awarded on July 14, 2020 under a full and open competition. The original solicitation was a combined synopsis/solicitation for commercial items under FAR...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $20,940.38 delivery order contract to Biomerieux, Inc. for supplies. The prime contractor Biomerieux, Inc. will perform the work at its Calverton, Maryland facility. The firm fixed price contract runs from May 18, 2022 through July 28, 2026. No additional details were provided regarding the specific supplies requested under the original solicitation. The HHS FDA regulates food and drugs to ensure...
The Department of Health and Human Services Food and Drug Administration awarded a $61,236 firm fixed price delivery order contract to Pacific Biosciences of California, Inc. for the purchase of reagents and supplies including AMPure PB, barcoded overhang adapter kits, Sequel binding and internal control kit, Sequel pipet tips V2, Sequel sequencing kit, Sequel SMRT cell oil, SMRT Cell 1M V3 tray, and SMRTbell Express template prep. Performance will take place in Silver Spring, Maryland through...
The U.S. Food and Drug Administration awarded a Firm Fixed Price Purchase Order contract to Pacific Biosciences of California, Inc., a small business manufacturer, for the delivery of PacBio Revio sequencing reagent kits or equal products. The $48,715.20 contract has a completion date of September 30, 2024 and will support research at the FDA's National Center for Toxicological Research. This award is associated with a larger $1 million single-award Indefinite Delivery Indefinite Quantity (IDIQ)...
The Department of Health and Human Services Food and Drug Administration awarded a $33,175 firm fixed price delivery order contract to Pacific Biosciences of California, Inc. for the purchase of reagents and supplies including AMPure PB, HiFi Express Template Prep Kit 2.0, Sequel Binding Kit 3.0, Sequel Sequencing Kit 3.0, and SMRT Cell 1M v3 LR Tray. The place of performance is Silver Spring, Maryland. The contract period runs from August 29, 2023 through March 30, 2024. As the prime...
The Department of Health and Human Services Food and Drug Administration awarded a $30,516.68 firm fixed price delivery order to Biomerieux Inc. for BIOMERIEUX KITS TO AGAINST CONTRACT NO 75F40121D00021. The prime contractor Biomerieux Inc. will provide products to the FDA in Irvine, California by July 28, 2026 in support of the FDA's medical device and diagnostic test evaluation activities. No set-aside designation was used for this award made on December 1, 2022 under the FDA's...
This is a federal contract award from the U.S. Food and Drug Administration (FDA) to Nova Biomedical Corporation, a leading manufacturer of advanced medical equipment and diagnostic devices. The contract, with a ceiling value of $160,625.00, was awarded on August 1, 2016 and has an ultimate completion date of July 31, 2021. The contract is a delivery order under the General Services Administration (GSA) Scientific Equipment and Services schedule (FSS-66) and is a firm fixed-price contract. The...
The U.S. Food and Drug Administration (FDA) has awarded a $39,657.00 firm fixed-price delivery order to Pacific Biosciences of California, Inc. (PacBio) under the company's existing $1 million Indefinite Delivery, Indefinite Quantity (IDIQ) contract with the agency. This delivery order is for the purchase of specific supplies and reagents to support the agency's use of PacBio's Sequel IIe long-read DNA/RNA sequencing platform. The award, made without a set-aside designation, is the latest task...
<p>This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Bioproximity LLC, a for-profit limited liability company, for global proteomic profiling sample preparation and data services. The contract has a ceiling value of $89,100.00 and an ultimate completion date of August 2, 2016. This contract award is not associated with a larger vehicle and does not have a set-aside designation.</p>